Israeli drug prevents 100% of COVID patients from deteriorating in trial
(Worthy News) – All 18 COVID-19 patients hospitalized with moderate or severe symptoms who received the drug Amor-18 developed by Israeli biotech company Amorphical recovered and were discharged in a few days, the company announced on Wednesday. Of the 19 individuals who were given a placebo, six had to be transferred to intensive care, and two died.
As part of compassionate care, two other patients in a very serious condition were given the drug. Both recovered and were discharged.
“Since the patients treated with the drug recovered within a few days and were released to their home, this was 100% successful,” said Dr. Nashat Abu Saleh, co-director of the coronavirus department at Ziv Medical Center in Safed, where the phase II clinical trial was conducted. [ Source: Jerusalem Post (Read More…) ]
💡 Did you know? One of the best ways you can support Worthy News is by simply leaving a comment and sharing this article.
📢 Social media algorithms push content further when there’s more engagement — so every 👍 like, 💬 comment, and 🔄 share helps more people discover the truth. 🙌